Mar 2, 2022 Fortis Life Sciences has entered into an agreement to acquire Abcore . Fortis Life Sciences based at Waltham, Massachusetts, United States. ” […]
Post-IPO Debt – Bio-Rad Laboratories
On Mar 2, 2022 Bio-Rad Laboratories closed a Post-IPO Debt round and raised $1,200,000,000 from investors, featuring lead investors . About the company: Bio-Rad Laboratories […]
Series A – Alimetry
On Mar 2, 2022 Alimetry closed a Series A round and raised $16,300,000 from IP Group, K1W1, Matū Fund, Movac, Uniservices, featuring lead investors Movac. […]
Series B – Diality
On Mar 2, 2022 Diality closed a Series B round and raised $24,000,000 from investors, featuring lead investors . About the company: Diality is located […]
Series A – Vesalius Therapeutics
On Mar 2, 2022 Vesalius Therapeutics closed a Series A round and raised $75,000,000 from Flagship Pioneering, featuring lead investors Flagship Pioneering. About the company: […]
Post-IPO Debt – AptarGroup
On Mar 2, 2022 AptarGroup closed a Post-IPO Debt round and raised $400,000,000 from investors, featuring lead investors . About the company: AptarGroup is located […]
Post-IPO Debt – Verano Holdings
On Mar 2, 2022 Verano Holdings closed a Post-IPO Debt round and raised $100,000,000 from Advanced Flower Capital, featuring lead investors . About the company: […]
Post-IPO Debt – Bio-Rad Laboratories
On Mar 2, 2022 Bio-Rad Laboratories closed a Post-IPO Debt round and raised $1,200,000,000 from investors, featuring lead investors . About the company: Bio-Rad Laboratories […]
Series A – Rialtic
On Mar 2, 2022 Rialtic closed a Series A round and raised $28,000,000 from F-Prime Capital, Health Velocity Capital, Noro-Moseley Partners, Oak HC/FT, featuring lead […]
Series A – Alimetry
On Mar 2, 2022 Alimetry closed a Series A round and raised $16,300,000 from IP Group, K1W1, Matū Fund, Movac, Uniservices, featuring lead investors Movac. […]